Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V260 (RotaTeq) in Healthy Japanese Infants
NCT00718237Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Merck & Co.. Started Aug 2008; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00718237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718237.